Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 10, 2015
RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatmentA K Hemanth Kumar, G Narendran, R S Kumar, et al.
New Biotechnology|March 12, 2010
Production optimization and properties of beta glucosidases from a marine fungus Aspergillus-SA 58K K Elyas, Abraham Mathew, Rajeev K Sukumaran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 22, 2011
Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in IndiaChandrasekaran Padmapriyadarsini, S Ramesh Kumar, Norma Terrin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 4, 2022
Trends in rifampicin and isoniazid resistance in patients with presumptive TBN Palani, M Premkumar, V Vaishnavee, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 10, 2016
Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosisB Velayutham, D Nair, T Kannan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 4, 2024
Programmatic implications of a sub-national TB prevalence survey in IndiaG Prathiksha, S Selvaraju, K Thiruvengadam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2003
Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosisPrema Gurumurthy, Geetha Ramachandran, A K Hemanth Kumar, et al.
Frontiers in Immunology|November 1, 2021
Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine ResponsesNathella Pavan Kumar, V V Banurekha, Girish Kumar C P, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus diseasePrema Gurumurthy, Geetha Ramachandran, A K Hemanth Kumar, et al.
Antimicrobial Agents and Chemotherapy|January 7, 2009
CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South IndiaGeetha Ramachandran, A K Hemanth Kumar, Sikhamani Rajasekaran, et al.
Pageof 8